Tadekinig Alfa
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Tadekinig Alfa, covering 2016-12-06 to 2026-03-03. Get the full timeline:
Most recent: Clinical Trial Update: Tadekinig Alfa (IL-18BP) Rescue Therapy for CAR T Cell Related Cytokine Release Syndrome (CRS) and HLH-like Syndrome [EARLY_Phase 1]